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Available online 4 January 2016Human foreskin ﬁbroblasts were used to generate the iPSC line iPSC-FH2.1 using the EF1a-hSTEMCCA-loxP vec-
tor expressing OCT4, SOX2, c-MYC and KLF4, in 5% O2 culture conditions. Stemness was conﬁrmed, as was
pluripotency both in vivo and in vitro, in normoxia and hypoxia. Human Embryonic Stem Cell (hESC) line WA-
09 and reprogrammed ﬁbroblast primary culture HFF-FM were used as controls.
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We obtained ﬁbroblasts from a healthy donor (primary culture HFF-
FM) and reprogrammed them using the STEMCCA vector to generate
the iPSC-FH2.1 line, in hypoxic conditions. Control lines iPSC-FN2.1
and iPS6.1 were generated in parallel, in normoxia, showing the same
results as iPSC-FH2.1, regarding their identity and purity. The iPSC-
FH2.1 line exhibited classic pluripotent stem cell morphology: small
cells with low nucleus:cytoplasm ratio, organized in colonies with de-
ﬁned borders that grew as three-dimensional structures (Fig. 1A). As
assessed by RT-qPCR, the expression of stemness markers POU5F1,
NANOG and C-MYC was induced when cells were reprogrammed,
compared to donor ﬁbroblasts (Fig. 1B). The expression of several
human stemness markers, including NANOG, POU5F1, SOX2, SSEA-4,
TRA1–60, TRA-1–81 and C-MYC, was also studied by immunostaining
(Fig. 1C), exhibiting clear expression of these markers when cultured
in normoxic and hypoxic conditions.
To assess if reprogramming had any effect on promoter DNA modi-
ﬁcations, we studied themethylation of the POU5F1 promoter (Fig. 1D).
We found that on a global level the POU5F1 promoter DNA region is
demethylated on several CpG islands in pluripotent cells; whereas in ﬁ-
broblasts that originated them the promoter is widely methylated. This
supports the occurrence of a profound remodeling of gene expression.
The transgene inserted by the STEMCCA lentiviral vectorwas report-
ed to become silenced after the reprogramming event (Sommer et al.,
2009). In order to study the endogenous expression of the endogenour
genes (as in Fig. 1A),we needed to be sure that the expression of the ex-
ogenous genes carried in the vector had been silenced and we could,the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. iPSC-FH2.1 iPSC line's stemness. Description of data: (A) Phase contrast image of representative colonies cultured in normoxia. Scale bars: 200 μm. (B) RT-qPCR analysis of expression of
stemness markers POU5F1, NANOG and C-MYC, in cells cultured either in normoxia or hypoxia for 72 h. Fold-induction vs. control is shown in bars representing the mean ± SEM of three
independent experiments. Inductions marked with * are signiﬁcant with respect to HFF-FM Fibroblasts in the same O2 condition, with p b 0.05. (C) Representative phase contrast and
immunostaining images for stemness markers, in normoxia and chronic hypoxia. Nuclei were stained with DAPI. Scale bars: 200 μm. (D) Demethylation levels of the POU5F1 promoter.
Each square represents a CpG and each section delimited by a black line represents an amplicon of PCR. The numbers indicate the base positions relative to the transcription start site.
(E) RT-qPCR analysis of the expression of the transgenes carried by the lentiviral reprogramming vector. STEMCCA is the vector itself used as a positive control. Fold-induction vs. control is
shown in bars representing the mean ± SEM of three independent experiments. Repression for hESC and iPSC line is signiﬁcant with p b 0.05.
301M. Questa et al. / Stem Cell Research 16 (2016) 300–303therefore, measure only endogenous expression from cDNA (Fig. 1E).
There is no detectable expression of the transgenes, as studied by RT-
qPCR on established iPSC lines, using primers speciﬁc for the exogenous
expression of the lentiviral genes.
Stemness markers that are induced during reprogramming are
down-regulated during differentiation. The stem cell line was in-
duced to undergo differentiation in normoxia and POU5F1, SOX2
and NANOG expression decreased between day 0 (undifferentiated
state) and day 21 of the differentiation process (Fig. 2A). Moreover,
germ layer lineage marker expression was induced during the differ-
entiation when cells were cultured both in normoxia or hypoxia for a
long-term period (Fig. 2B). Germ layer markers were all inducedfrom a basal expression at day 0 to an increased expression at day
7 or day 21, depending on the kinetics of each gene. All the cell
lines were able to differentiate in vitro to the three germ layers. The
presence of differentiation marker proteins was also observed by im-
munostaining (Fig. 2C), both when grown in normoxia or hypoxia.
The iPSC lines established also showed pluripotency in vivo, being
able to generate teratomas in immunosuppressed mice (Fig. 2D).
The teratomas generated had cells of the three germ layers, which
could be assigned to different tissues and structures. Finally, we
found that all the cell lines generated and studied possessed a nor-
mal human karyotype, and there were no signiﬁcant genetic anoma-
lies introduced by the reprogramming process (Fig. 2E).
Fig. 2. iPSC-FH2.1 iPSC line's pluripotency and chromosomal integrity. (A) RT-qPCR analysis of stemnessmarkers POU5F1, SOX2 andNANOG expression during differentiation, in normoxia.
D0: day 0 of differentiation (control), D21: D21 post-differentiation induction. Fold-induction vs. control is shown inbars representing themean±SEMof three independent experiments.
Repression is signiﬁcantwith p b 0.05. (B) RT-qPCR analysis of the expression of endodermmarkersαFP and SOX17, mesodermmarkersMESP-1 andMYOD, and ectodermmarkersNES and
TUBB3, in iPSC-FH2.1 cultured innormoxia or hypoxia. Representative images of 3 independent experiments are shown.D7: day 7. (C). Representative phase contrast and immunostaining
images for endoderm markers AFP and GATA-4, mesoderm marker NKX2.5 and ectoderm marker NESTIN, GFAP and PAX6 in iPSC-FH2.1, cultured in normoxia or hypoxia. Nuclei were
stained with DAPI. Scale bars: 200 μm. (D) Karyogram of iPSC-FH2.1 line in normoxia. Karyotype is a normal 46 chromosome human karyotype. (E) Representative brightﬁeld
microscopy images of hematoxylin–eosin stained teratoma sections generated in nude mice, showing the presence of tissues from the three germ layers. Scale bars: 200 μm.
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Cell culture
hESC line WA-09 was purchased from WiCell Research Institute.
Cell lines were maintained and differentiated, according to
(Romorini et al., 2012; Scassa et al., 2011; Sommer et al., 2009).The HFF-FM ﬁbroblast primary culture was established according
to (Meng et al., 2008) from a sample of human foreskin, obtained
after informed consent. The protocol was approved by the Ethics
Committee of our institution.
Incubation was performed at 5% CO2 levels, in humidiﬁed atmo-
sphere at 37 °C. Normoxic cultures were performed at atmospheric O2
levels. For hypoxia, cells were cultured at 5% O2.
303M. Questa et al. / Stem Cell Research 16 (2016) 300–303Lentiviral vector production and iPSC generation
The EF1a-hSTEMCCA-loxP (STEMCCA) lentiviral cassette and helper
plasmids were generously provided by Dr. Gustavo Mostoslavsky and
lentiviral vectors were produced as previously described (Sommer et
al., 2009), with minor modiﬁcations. Brieﬂy, the ﬁve-plasmid transfec-
tion system was introduced into HEK-293 T cells using the FuGENE6
transfection reagent (Roche, 1814443), according to manufacturer's
recommendations. Optimal transfection efﬁciency was obtained using
a FuGENE6:DNA ratio of 6:1. Lentiviral vector-containing supernatants
were collected 48, 64, and 80 h post-transfection, ﬁltered through a
0.45 μm low-binding ﬁlter and concentrated in an Amicon Ultra 15
100.000 NMWL column (EMD Millipore, UFC910024), according to
manufacturer's instructions. Concentrate was aliquoted, stored in liquid
nitrogen, and used within 12 months. Transduction efﬁciency of the
lentiviral concentrate was assessed on the ﬁbroblast line HFF-FM
using concentrate deﬁned as: Lentiviral Particles/μl = Number of
Oct4 + DAPI + nuclei/μl of concentrate used for assay.
RT-Quantitative real time PCR (RT-qPCR) and endpoint PCR
RNA isolation and cDNA synthesis were performed as previously de-
scribed (Romorini et al., 2012). cDNA sampleswere diluted ten-fold. RT-
qPCRwas conducted using Sybr Green ER qPCR SuperMix (Invitrogen),
following manufacturer's instructions, at an annealing temperature of
60 °C in a StepOne Plus Real Time PCR System (Applied Biosystems)
with StepOne Software v2.1. A list of primers is shown in Supplementa-
ry Table S1. In all hypoxia experiments, housekeeping gene HPRT1was
used. In all other cases, housekeeping gene GAPDHwas used.
Endpoint PCR was performed as previously described (Romorini
et al., 2012).
To assess expression of transgenes, RT-qPCR was performed on
cDNA from iPSC mRNA or the STEMCCA DNA as a positive control,
using primers that bridge over two of the four transgenes on the
STEMCCA vector sequence. This design allows ampliﬁcation of only
cDNA generated from the exogenous mRNA expression of these genes
(Sommer et al., 2009). A list of primers is shown in Supplementary
Table S1.
Promoter methylation analysis was conducted as previously de-
scribed (Luzzani et al., 2015).
Immunostaining
Immunostainingwas conducted as previously described (Scassa et al.,
2011) using primary antibodies: anti-OCT-3/4 (SC-5279), SSEA4 (SC-
21704), AFP (SC-166325), TRA1–60 (SC-21705), TRA-1–81 (SC-21706),
GATA-4 (SC-25310) (all from Santa Cruz Biotechnology–SCB–), NANOG
(Cell Signaling, #4903), SOX2 (Cell Signaling, #3579), NESTIN (Millipore,
AB5922), NKX2.5 (SCB, SC-14033), C-MYC (Cell Signaling, #5605), GFAP
(Millipore, AB5804), PAX6 (Abcam,AB5790), according tomanufacturer's
instructions. Fluorescent secondary antibodies, Alexa Fluor (AF)-488-con-
jugated anti-mouse IgG (A11029), AF-488-conjugated anti-rabbit IgG
(A11034), AF-568-conjugated anti-mouse IgG (A11031), and AF-568-
conjugated anti-rabbit IgG (A11036) (all Molecular Probes/Invitrogen)
were used according to manufacturer's instructions.
Teratoma formation and hematoxylin–eosin staining
Cells were grown to conﬂuence and dissociated. 4 × 106 cells in 1/4
Matrigel dilution were injected subcutaneously in the dorsal ﬂanks of6–8 week-old male N:NIH(S)-Fox1nu nudemice. After tumor formation,
animals were anesthetized in a CO2 atmosphere chamber and sacriﬁced
by cervical dislocation. Tumors were dissected, ﬁxed, embedded in par-
afﬁn, hematoxylin–eosin (Biopur) stained, according to manufacturer's
instructions, mounted on microscope slides and photographed under a
Nikon Eclipse E400microscope with a Nikon Coolpix-S4 digital camera.
Karyotyping
Cells were cultured to exponential growth rate, colchicine (Sigma-
Aldrich)was added and cells incubated for 1.5–3 h. Cellswere dissociat-
ed, KCl hypotonic solutionwas added, and the samplewas incubated for
20min. Cells were resuspended in glacial acetic acid/methanol 3:1 (Van
Rossum, JT Baker), with a 24-hour incubation at 4 °C. Microscope slides
were prepared and stained with Giemsa (Biopur) in Phosphate Buffer
Solution pH= 7, rinsed, dried and mounted, observed under an Olym-
pus BX60 microscope at 1000× magniﬁcation and photographed using
an Olympus NO-C-5060 camera. 50metaphases were analyzed for each
cell line.
Statistical analysis
Results are shownasmean±SEM. pValues below0.05were consid-
ered statistically signiﬁcant. Student's t test was used to determine sig-
niﬁcant differences between means, except for the transgene
expression study, where a One-Way ANOVA followed by Dunnett's
multiple comparisons was used.
Ethics, consents and permissions
The FLENI Ethics Committee approved all animal and human proce-
dures. All human samples were obtained after written informed con-
sent. The work described was carried out in accordance with The Code
of Ethics of the World Medical Association.
Animal experimentswere carried out in accordancewith the recom-
mendations in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2015.12.026.
References
Luzzani, C., Neiman, G., Garate, X., Questa, M., Solari, C., et al., 2015. A therapy-grade pro-
tocol for differentiation of pluripotent stem cells into mesenchymal stem cells using
platelet lysate as supplement. Stem Cell Res. Ther. 6, 6.
Meng, G., Liu, S., Krawetz, R., Chan, M., Chernos, J., et al., 2008. A novel method for gener-
ating xeno-free human feeder cells for human embryonic stem cell culture. Stem
Cells Dev. 17, 413–422.
Romorini, L., Scassa, M.E., Videla Richardson, G., Bluguermann, C., Jaquenod de Giusti, C.,
et al., 2012. Activation of apoptotic signalling events in human embryonic stem
cells upon Coxsackievirus B3 infection. Apoptosis 17, 132–142.
Scassa, M.E., Jaquenod de Giusti, C., Questa, M., Pretre, G., Richardson, G.A., et al., 2011.
Human embryonic stem cells and derived contractile embryoid bodies are suscepti-
ble to Coxsakievirus B infection and respond to interferon Ibeta treatment. Stem
Cell Res. 6, 13–22.
Sommer, C.A., Stadtfeld, M., Murphy, G.J., Hochedlinger, K., Kotton, D.N., et al., 2009. In-
duced pluripotent stem cell generation using a single lentiviral stem cell cassette.
Stem Cells 27, 543–549.
